We enable life

Uni Zurich Spin-off

we are a MedTech spin-off of the University and University Hospital of Zurich that provides a method to reduce the risk of preterm birth related to fetoscopic interventions.

Born to deliverOur Mission

The project resulted from a combined doctoral study from the Ecole Polytechnique Federale de Lausanne (EPFL) and UniversitätsSpital Zürich (USZ). KOVE is the sum of years of research towards enabling surgeons to have a secure way to perform pre-natal treatment, which suffers from a high risk of preterm birth after the surgery. This side-effect is seen to be the greatest limitation for the progress of fetal therapy.


Understand, Create, Save

We save babies that are now doomed to death. We give surgeons a reliable tool to work with. We avoid huge expenses in neonatal care for society.

Meet our Team

Dr. Yannick Devaud

Founder, CEO, Ph.D in Biotechnology
and Bioengineering

Dr. Kurt Ruffieux

Co-Founder, CTO, Ph.D in Material Sciences

Helena Tronnier

Msc in Biomedical engineering, Head of R&D


Let’s save lives together